Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report

Thyroid cancer metastasizes in 4% of cases. Approximately two-thirds of these patients are refractory to radioactive iodine-131 (RAI) therapy and have a poor 10-year survival prognosis. Treatment with tyrosine kinase inhibitors (TKIs) may be administered in selected RAI-refractory patients. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Porcelli, Tommaso, Sessa, Francesca, Caputo, Angela, Catalini, Christian, Salvatore, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966541/
https://www.ncbi.nlm.nih.gov/pubmed/29867775
http://dx.doi.org/10.3389/fendo.2018.00244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966541/
https://www.ncbi.nlm.nih.gov/pubmed/29867775
http://dx.doi.org/10.3389/fendo.2018.00244

Ejemplares similares